NYT > Science

Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients.

May 11, 2025 - 23:05
 0
Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug
CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients.
Read More

Tags:

Previous Article

No, Agriculture & Meat Aren’t A Bigger Driver Of Climate Change Than Fossil Fuels

Next Article

Surging Solar Power, Booming EV Sales, & Robotaxi Safety — Top 12 Stories of the...

Related Posts

Your Cat May or May Not Love You, but It Knows Your Scent

Your Cat May or May Not Love You, but It Knows Your Scent

May 28, 2025  0

As the Trump Administration Slashes Federal Spending, Scientists Consider Leaving the U.S.

As the Trump Administration Slashes Federal Spending, S...

Jun 4, 2025  0

Regulators Approve Lenacapavir for H.I.V. Prevention

Regulators Approve Lenacapavir for H.I.V. Prevention

Jun 18, 2025  0